News
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
Zomedica Corp. announces collaboration with Boehringer Ingelheim Animal Health USA Inc. to enhance early detection along with treatment and monitoring of pituitary pars intermedia dysfunction (PPID) in horses -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Zomedica reports record $10 million quarterly revenue, 20th consecutive year-over-year growth. Financial highlights and strategic outlook unveiled -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th "Fourth Friday at Four" Investor Webinar
Zomedica Corp. announces upcoming investor webinar to discuss full-year 2025 financial results, equine veterinary market insights, and product portfolio. Event to feature live Q&A session -
